Beam Therapeutics (BEAM) Tax Provisions (2022 - 2025)

Beam Therapeutics (BEAM) has 4 years of Tax Provisions data on file, last reported at -$16.8 million in Q4 2025.

• On a quarterly basis, Tax Provisions changed N/A year-over-year to -$16.8 million in Q4 2025; TTM through Dec 2025 was -$16.8 million, a 43174.36% decrease from a year earlier, with the FY2025 full-year figure at -$16.8 million, down 43174.36% from the prior year.
• Tax Provisions for Q4 2025 stood at -$16.8 million, down from $39000.0 in the prior quarter.
• Over the last five years, Tax Provisions for BEAM reached as high as $2.4 million in Q3 2022 and fell as low as -$16.8 million in Q4 2025.
• Historically, Tax Provisions has averaged -$2.4 million across 4 years, with a median of $1.0 million in 2022.
• On a YoY basis, Tax Provisions climbed as much as 40.0% in 2023 and fell as far as 40.0% in 2023.
• Year by year, Tax Provisions stood at $1.0 million in 2022, then soared by 40.0% to $1.4 million in 2023, then tumbled by 97.21% to $39000.0 in 2024, then slumped by 43174.36% to -$16.8 million in 2025.
• Per Business Quant data, the three most recent Tax Provisions figures were -$16.8 million in Q4 2025, $39000.0 in Q2 2024, and $1.4 million in Q4 2023.